AstraZeneca, the renowned pharmaceutical giant, has unveiled plans to invest $1.5 billion in a cutting-edge antibody drug conjugate (ADC) manufacturing facility in Singapore, marking a significant milestone in the company's history. The state-of-the-art factory is poised to become operational
In an industry where time-to-market is critical, a strategic collaboration between AGC Biologics, a global leader in biopharmaceutical development, and BioConnection, an aseptic filling expert, may be the key to unlocking faster pathways from laboratory to patient. As biotechnology firms grapple
Novo Holdings, a prominent Danish investment firm with a focus on life sciences, has recently cemented its standing in the biopharma manufacturing industry through a strategic acquisition. Securing a majority stake in Single Use Support, Novo Holdings ventures further into an increasingly vital
The biotech industry is poised for transformative growth, fueled by scientific breakthroughs and the application of cutting-edge technologies. In this nexus of innovation, 21st.BIO stands out with its recent announcement of a new pilot plant in the heart of Europe's biotech landscape. This
ChargePoint Technology is taking a significant leap to scale up its manufacturing capabilities amid surging demand for single-use disposable systems in the pharmaceutical sector. By pouring investment into a state-of-the-art facility in Speke, Liverpool, the company aims to strengthen its position
BioNTech, the German biotechnology company known for its pivotal role in creating a COVID-19 vaccine with Pfizer, has inaugurated a state-of-the-art modular mRNA vaccine production facility in Kigali, the capital of Rwanda. This initiative marks a significant step toward health equality and local
